Back
Actinium Pharmaceuticals Stock Price Chart
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm
Sell
24
ATNM
Actinium Pharmaceuticals
Last Price:
1.80
Seasonality Move:
4.44%
7 Day Trial
ALL ACCESS PASS
$
7
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATNM is experiencing slight buying pressure.
Actinium Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.86 | Sell |
| 20-day SMA: | 1.92 | Sell |
| 50-day SMA: | 4.02 | Sell |
| 200-day SMA: | 6.27 | Sell |
| 8-day EMA: | 1.85 | Sell |
| 20-day EMA: | 2.14 | Sell |
| 50-day EMA: | 3.56 | Sell |
| 200-day EMA: | 5.9 | Sell |
Actinium Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.52 | Sell |
| Relative Strength Index (14 RSI): | 30.88 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.82 - 2.04) | Sell |
| Bollinger Bands (100): | (3.26 - 8.88) | Sell |
Actinium Pharmaceuticals Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Actinium Pharmaceuticals Stock
Is Actinium Pharmaceuticals Stock a Buy?
- Actinium Pharmaceuticals share price is 1.82 while ATNM 8-day simple moving average is 1.86, which is a Sell signal.
- The stock price of ATNM is 1.82 while Actinium Pharmaceuticals 20-day SMA is 1.92, which makes it a Sell.
- Actinium Pharmaceuticals 50-day simple moving average is 4.02 while ATNM share price is 1.82, making it a Sell technically.
- ATNM stock price is 1.82 and Actinium Pharmaceuticals 200-day simple moving average is 6.27, creating a Sell signal.
ATNM Technical Analysis vs Fundamental Analysis
Sell
24
Actinium Pharmaceuticals (ATNM)
is a Sell
Is Actinium Pharmaceuticals a Buy or a Sell?
-
Actinium Pharmaceuticals stock is rated a Sell
The current Actinium Pharmaceuticals [ATNM] share price is $1.82. The Score for ATNM is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
Actinium Pharmaceuticals Stock Info
Market Cap:
56.7M
Price in USD:
1.82
Share Volume:
236.21K
Actinium Pharmaceuticals 52-Week Range
52-Week High:
10.24
52-Week Low:
1.33
Sell
24
Actinium Pharmaceuticals (ATNM)
is a Sell
Actinium Pharmaceuticals Share Price Forecast
-
What is the Actinium Pharmaceuticals stock price today?
The Actinium Pharmaceuticals stock price is 1.82 USD today. -
Will ATNM stock go up or go down?
Actinium Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Actinium Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Actinium Pharmaceuticals is overvalued.
Is Actinium Pharmaceuticals Stock a Buy?
- Actinium Pharmaceuticals share price is 1.82 while ATNM 8-day exponential moving average is 1.85, which is a Sell signal.
- The stock price of ATNM is 1.82 while Actinium Pharmaceuticals 20-day EMA is 2.14, which makes it a Sell.
- Actinium Pharmaceuticals 50-day exponential moving average is 3.56 while ATNM share price is 1.82, making it a Sell technically.
- ATNM stock price is 1.82 and Actinium Pharmaceuticals 200-day simple moving average is 5.90, creating a Sell signal.
Fundamental Analysis of Actinium Pharmaceuticals
Is Actinium Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.09 per share, an increase this year of $0.62 per share, and an increase next year of $0.66 per share.
Technical Analysis of Actinium Pharmaceuticals
Should I short Actinium Pharmaceuticals stock?
- ATNM Moving Average Covergence Divergence (MACD) indicator is -0.52, suggesting Actinium Pharmaceuticals is a Sell
- Actinium Pharmaceuticals Relative Strength Index (RSI) is 30.88, which suggest Actinium Pharmaceuticals is oversold
- The Bollinger Bands (25) for Actinium Pharmaceuticals is (1.82 - 2.04), which suggest Actinium Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Actinium Pharmaceuticals is (3.26 - 8.88), which suggest Actinium Pharmaceuticals is a Sell
* Actinium Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.